AstraZeneca, Oxford University team up to develop Covid-19 vaccine
30th Apr 2020 10:07
(Sharecast News) - Pharma giant AstraZeneca said it had teamed up with the University of Oxford to develop and distribute a potential coronavirus vaccine with the first results from clinical trials set to arrive over the next few months.
Read moreAstraZeneca maintains FY guidance as Q1 revenues grow
29th Apr 2020 07:43
(Sharecast News) - AstraZeneca maintained its full-year guidance on Wednesday as it posted a rise in first-quarter profit and revenue.
Read moreWednesday preview: US Federal Reserve, Astra Zeneca in focus
28th Apr 2020 14:59
(Sharecast News) - The focus in the middle of the week will be on the US central bank with investors keen to know the Federal Reserve's take on the current state of economies and financial markets around the world.
Read moreMonday broker round-up
27th Apr 2020 13:54
(Sharecast News) - South32: Jefferies downgrades to underperform with a target price of 80p.
Read moreAstrazeneca's Lynparza shows promise in Phase III trial
24th Apr 2020 07:59
(Sharecast News) - Astrazeneca and Merck said their Lynparza prostate cancer treatment had met a second goal in a trial for patients suffering from the metastatic castration-resistant version of the disease.
Read moreAstraZeneca to trial diabetes drug on Covid-19 patients
23rd Apr 2020 13:12
(Sharecast News) - UK based pharma company AstraZeneca and Saint Luke's Mid America Heart Institute have started Phase III trials on the use of diabetes drug Farxiga to minimise the risk of serious complications from the Covid-19 disease.
Read moreResearch into Covid-19 antibody therapy gaining ground - report
20th Apr 2020 14:10
(Sharecast News) - Antibody therapy for Covid-19 may be available by the autumn, according to a report on biotechnology firms carrying out research.
Read moreWednesday broker round-up
15th Apr 2020 13:36
(Sharecast News) - Reckitt Benckiser Group: Credit Suisse upgrades to neutral with a target price of 5,900p.
Read moreAlmost a third of FTSE 100 cut or scrap dividends
15th Apr 2020 12:01
(Sharecast News) - Almost one-third of FTSE 100 companies have cut or scrapped their dividends during the coronavirus crisis, leaving investors relying on 10 companies for two-thirds of the index's likely payouts in 2020, research shows.
Read moreAstraZeneca surges on Covid-19 drug trial
14th Apr 2020 08:40
(Sharecast News) - AstraZeneca shares surged on Tuesday after the pharmaceuticals giant said it will start a clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response associated with Covid-19 in severely ill patients.
Read moreMonday broker round-up
6th Apr 2020 12:43
(Sharecast News) - Anglo American: RBC Capital Markets downgrades to sector perform with a target price of 1,500p.
Read moreUK cough and cold medicine prices rise 10.7%
2nd Apr 2020 14:42
(Sharecast News) - The price of cough and cold medicine rose by 10.7% last week as retailers take advantage of the rise in demand due to the coronavirus outbreak.
Read moreAstraZeneca gets FDA approval, stops kidney drug trial after 'overwhelming efficacy'
30th Mar 2020 08:11
(Sharecast News) - Biopharmaceutical giant AstraZeneca said on Monday that two of its top-selling drugs had shown advances in the treatment of deadly diseases.
Read moreAstraZeneca hyperkalaemia drug gets approval in Japan
26th Mar 2020 09:29
(Sharecast News) - AstraZeneca said on Thursday that its Lokelma drug has been approved in Japan for the treatment of patients with hyperkalaemia - elevated levels of potassium in the blood.
Read moreAstraZeneca's Lynparza gets new orphan designation in Japan
19th Mar 2020 13:38
(Sharecast News) - AstraZeneca announced on Thursday that Lynparza, or 'olaparib', has been granted orphan drug designation in Japan for the maintenance treatment of germline BRCA-mutated (gBRCAm) curatively unresectable pancreatic cancer.
Read more